Human platelet signaling defect characterized by impaired production of inositol-1,4,5-triphosphate and phosphatidic acid and diminished Pleckstrin phosphorylation: evidence for defective phospholipase C activation

Blood. 1996 Sep 1;88(5):1676-83.

Abstract

Signal transduction on platelet activation involves phosphoinositide-specific phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositides and formation of inositol-1,4,5-triphosphate [I(1,4,5)P3], which mediates Ca2+ mobilization, and diacylglycerol (DG), which activates protein kinase C (PKC) to phosphorylate a 47-kD protein (Pleckstrin). We studied these events in two related patients previously reported (Blood 74:664, 1989) to have abnormal aggregation and 14C-serotonin secretion, and impaired intracellular Ca2+ mobilization in response to several agonists. Thrombin-induced I(1,4,5)P3 and phosphatidic acid formation were diminished. Pleckstrin phosphorylation was impaired on activation with thrombin, platelet-activating factor, and ionophore A23187, but was normal with PKC activator 1,2-dioctonyl-sn-glycerol (DiC8). Ca2+ mobilization induced by guanosine triphosphate (GTP) analog guanosine 5'-0-(3 thiotriphosphate) (GTP gamma S) was diminished. Pretreatment with either A23187 or DiC8 did not correct the impaired adenine diphosphate-induced secretion; however, upon stimulation with A23187 plus DiC8, pleckstrin phosphorylation and secretion were normal, indicating that both PKC activation and Ca2+ mobilization are essential for normal secretion. We conclude that these patients have a unique inherited platelet defect in formation of two key intracellular mediators [I(1,4,5)P3 and DG] and in the responses mediated by them due to a defect in postreceptor mechanisms of PLC activation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Adult
  • Blood Platelets / metabolism
  • Blood Proteins / metabolism*
  • Calcimycin / pharmacology
  • Calcium / metabolism
  • Diglycerides / biosynthesis
  • Enzyme Activation
  • Female
  • Hemorrhagic Disorders / blood
  • Hemorrhagic Disorders / enzymology*
  • Humans
  • Inositol 1,4,5-Trisphosphate / biosynthesis*
  • Male
  • Middle Aged
  • Myosin Light Chains / metabolism
  • Phosphatidic Acids / deficiency*
  • Phosphatidylinositol Diacylglycerol-Lyase
  • Phosphoproteins*
  • Phosphoric Diester Hydrolases / metabolism*
  • Phosphorylation
  • Platelet Activating Factor / pharmacology
  • Platelet Aggregation / drug effects
  • Protein Processing, Post-Translational*
  • Serotonin / metabolism
  • Signal Transduction / physiology*
  • Thrombin / pharmacology

Substances

  • Blood Proteins
  • Diglycerides
  • Myosin Light Chains
  • Phosphatidic Acids
  • Phosphoproteins
  • Platelet Activating Factor
  • platelet protein P47
  • Serotonin
  • Calcimycin
  • Adenosine Diphosphate
  • Inositol 1,4,5-Trisphosphate
  • Phosphoric Diester Hydrolases
  • Thrombin
  • Phosphatidylinositol Diacylglycerol-Lyase
  • Calcium